Niche Biopharmaceuticals LLC

SHOREWOOD, MN · Founded 2020 · CIK 0001846144 · Biotech · Private

NB2, a coupled anti-infective immunomodulatory therapeutic molecule for dermatological and wound-healing indications

nichebiopharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$525K
4 Form D · May 2026
5 months since last filing
Contracts
—
No federal contracts on record
Patents
4
3 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$25,000
Private capital raisedForm D · SEC$200,000
Private capital raisedForm D · SEC$100,000
Private capital raisedForm D · SEC$200,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2768Wave Bye Inc.—$852K
2769DIAVACS, INC.—$850K
2770OCEANYX PHARMACEUTICALS, INC.——
2771Niche Biopharmaceuticals LLC—$525K
2772LACERTA THERAPEUTICS, INC.—$500K
2773StaphOff Biotech, Inc.—$25K
2774Arsenal Biosciences—$579M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Paul BrennanDirector
  • Robert KlemDirector
  • Dayton ReardanDirector · Executive Officer · Promoter
  • Daniel SaccaniDirector
  • Patrick SchlievertDirector

Patents

USPTO · 3 granted of 4

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.